NOTE 7 - LOSS PER SHARE

3 Months Ended

Mar. 31, 2024

The computation of basic loss per share is based on the weighted average number of shares outstanding during each period.

The following data show the amounts used in computing loss per share for the three months ended:

		March 31, 2024		March 31, 2023

Net loss (numerator)	$	(39,653)	$	(23,636)
Weighted average shares outstanding (denominator)		1,135,194		1,135,194
Basic and fully diluted net loss per share amount	$	(0.03)	$	(0.02)

The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus the common stock equivalents as detailed in the following chart. For the three months ended March 31, 2024 and 2023, the inclusion of these shares on the statements of operations would have resulted in a weighted average shares fully diluted number that was anti-dilutive, and as such they are excluded.

The following data show the fully diluted shares for the three months ended March 31, 2024 and 2023:

	March 31,
	2024	2023

Basic weighted average shares outstanding	1,135,194	1,135,194
Convertible debt	15,061	14,694
Total	1,150,255	1,149,888

BIOETHICS LTD 10-Q